Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

The Death Gene

Popular

Description

The cell

A Novel Means of Greatly Extending Lifespan and Resistance to Oxidative Stress

Ten fold increase in lifespan is observed for the deletion of a single gene

The findings in C. elegans are that the deletion of a specific domain of the phosphoinositol-3-kinase (PI3K) gene results in a 10-fold increase in life span.

This pathway, and this gene, is known to limit lifespan on C. elegans and, with lesser evidence, thought to affect life span in dipteran insects and mammals. The significance of the PI3K deletion rather than the mutations affecting the gene opens novel opportunities for impacting life span.

Current studies implicate the elimination of residual inositol-3,4,5-kinase activity as a possible key factor, and also suggest other directions for investigation that may lead to improvements beyond those within our ability to genetically or pharmacologically extend life span.

Ongoing research seeking insight into the utilization of these findings.

Development status

Early Stage

Patent information

U.S. Provisional Patent pending Conversion to Utility Patent

Type of business relationship sought

Seeking partner to develop and commercialize this technology

Licensing Status

Available for exclusive licensing

 

Ad details

Ad ID : 259

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

I want to give process knowhow and NON GMO...
n/a
334 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
357 Views
 Company portfolio: Manufacturing over 100...
700 Views
Objective: To enter into EU domain procuring...
606 Views
Objective: To enter into EU domain grabbing a...
309 Views
OUT-LICENSING DOSSIER OF ALIMEMAZINE TABLETS OF...
382 Views
Please contact me.  if you need...
912 Views